Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 87441-0003-01
- Manufacturer
- Unit Dose Solutions, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- April 13, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA207000
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
87441-0003-01Selected30 TABLET in 1 BLISTER PACK (87441-003-01)
External Resources